Foundry Partners, LLC Bristol Myers Squibb CO Transaction History

Foundry Partners, LLC

$1.82 Billion
Q1 2025

A detailed history of Foundry Partners, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Foundry Partners, LLC holds 385,025 shares of BMY stock, worth $18.1 Million. This represents 1.29% of its overall portfolio holdings.

Number of Shares

385,025

Previous 406,683 5.33%

Holding current value

$18.1 Million

Previous $23 Million 2.09%

% of portfolio

1.29%

Previous 1.2%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 05, 2025	SELL	$53.9 - $63.11 $1.17 Million - $1.37 Million	-21,658 Reduced 5.33%	385,025 $23.5 Million
Q4 2024 Feb 12, 2025	BUY	$51.92 - $59.94 $21.1 Million - $24.4 Million	406,683 New	406,683 $23 Million
Q4 2021 Jan 26, 2022	SELL	$53.63 - $62.52 $31.4 Million - $36.7 Million	-586,405 Closed	0 $0
Q3 2021 Oct 14, 2021	BUY	$59.17 - $69.31 $4.95 Million - $5.8 Million	83,647 Added 16.64%	586,405 $34.7 Million
Q2 2021 Jul 23, 2021	BUY	$61.91 - $67.42 $437,703 - $476,659	7,070 Added 1.43%	502,758 $33.6 Million
Q1 2021 May 12, 2021	BUY	$59.34 - $66.74 $3.08 Million - $3.46 Million	51,900 Added 11.69%	495,688 $31.3 Million
Q4 2020 Feb 04, 2021	BUY	$57.74 - $65.43 $8.35 Million - $9.46 Million	144,583 Added 48.32%	443,788 $27.5 Million
Q3 2020 Oct 23, 2020	SELL	$57.43 - $63.64 $119,167 - $132,053	-2,075 Reduced 0.69%	299,205 $18 Million
Q2 2020 Aug 03, 2020	BUY	$54.82 - $64.09 $2.58 Million - $3.02 Million	47,077 Added 18.52%	301,280 $17.7 Million
Q1 2020 May 08, 2020	BUY	$46.4 - $67.43 $55,262 - $80,309	1,191 Added 0.47%	254,203 $14.2 Million
Q4 2019 Feb 10, 2020	BUY	$49.21 - $64.19 $12.5 Million - $16.2 Million	253,012 New	253,012 $16.2 Million
Q2 2018 Jul 19, 2018	SELL	$50.53 - $62.98 $9.73 Million - $12.1 Million	-192,577 Closed	0 $0
Q1 2018 May 16, 2018	SELL	$59.92 - $68.98 $5.52 Million - $6.36 Million	-92,193 Reduced 32.37%	192,577 $12.2 Million
Q4 2017 Jan 25, 2018	SELL	$59.94 - $65.35 $836,222 - $911,697	-13,951 Reduced 4.67%	284,770 $17.5 Million
Q3 2017 Oct 31, 2017	BUY	$55.23 - $63.74 $16.5 Million - $19 Million	298,721	298,721 $19 Million

Others Institutions Holding BMY

# of Institutions

2,808

Shares Held

1.59B

Call Options Held

25.9M

Put Options Held

23.9M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $99.9B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Foundry Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Foundry Partners, LLC with notifications on news.

Account

Foundry Partners, LLC Bristol Myers Squibb CO Transaction History